Hepion Pharmaceuticals Stock Analysis

Hepion Stock Analysis Notes

About 17.0% of the company shares are owned by institutional investors. The company has price-to-book (P/B) ratio of 0.67. Some equities with similar Price to Book (P/B) outperform the market in the long run. Hepion Pharmaceuticals recorded a loss per share of 12.42. The entity last dividend was issued on the 3rd of June 2019. The firm had 1:20 split on the 11th of May 2023. Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the United States. Hepion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Edison, New Jersey. Hepion Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 20 people. To learn more about Hepion Pharmaceuticals call BSc BSc at 732 902 4000 or check out https://www.hepionpharma.com.

Hepion Pharmaceuticals Investment Alerts

Hepion Pharmaceuticals Upcoming and Recent Events

Hepion Largest EPS Surprises

View All Earnings Estimates

Hepion Stock Institutional Investors

Note, although Hepion Pharmaceuticals' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Hepion Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 9.46 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Hepion Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Hepion Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Hepion Profitablity

Management Efficiency

Hepion Pharmaceuticals has return on total asset (ROA) of (0.6311) % which means that it has lost $0.6311 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.1848) %, meaning that it created substantial loss on money invested by shareholders. Hepion Pharmaceuticals' management efficiency ratios could be used to measure how well Hepion Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. As of April 16, 2024, Return On Tangible Assets is expected to decline to -0.7. In addition to that, Return On Capital Employed is expected to decline to -0.82. At present, Hepion Pharmaceuticals' Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Total Current Assets is expected to grow to about 68.2 M, whereas Other Assets are forecasted to decline to about 465.6 K.

Technical Drivers

As of the 16th of April 2024, Hepion Pharmaceuticals retains the Risk Adjusted Performance of (0.01), market risk adjusted performance of (0.16), and Standard Deviation of 7.63. Hepion Pharmaceuticals technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Simply put, you can use this information to find out if the firm will indeed mirror its model of historical price patterns, or the prices will eventually revert. We were able to interpolate data for thirteen technical drivers for Hepion Pharmaceuticals, which can be compared to its competitors. Please check out Hepion Pharmaceuticals information ratio, value at risk, as well as the relationship between the Value At Risk and kurtosis to decide if Hepion Pharmaceuticals is priced fairly, providing market reflects its last-minute price of 2.19 per share. Please also validate Hepion Pharmaceuticals jensen alpha, which is currently at (0.30) to confirm the company can sustain itself at a future point.

Hepion Pharmaceuticals Price Movement Analysis

Hepion Pharmaceuticals Insider Trading Activities

Hepion Pharmaceuticals Predictive Daily Indicators

Hepion Pharmaceuticals Corporate Filings

Hepion Pharmaceuticals Forecast Models

Hepion Pharmaceuticals' time-series forecasting models are one of many Hepion Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Hepion Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Hepion Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Hepion shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Hepion Pharmaceuticals. By using and applying Hepion Stock analysis, traders can create a robust methodology for identifying Hepion entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Hepion analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Hepion analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Hepion Pharmaceuticals stock analysis indicators help investors evaluate how Hepion Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Hepion Pharmaceuticals shares will generate the highest return on investment. By understating and applying Hepion Pharmaceuticals stock analysis, traders can identify Hepion Pharmaceuticals position entry and exit signals to maximize returns.

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hepion Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. For information on how to trade Hepion Stock refer to our How to Trade Hepion Stock guide.You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

When running Hepion Pharmaceuticals' price analysis, check to measure Hepion Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hepion Pharmaceuticals is operating at the current time. Most of Hepion Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Hepion Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hepion Pharmaceuticals' price. Additionally, you may evaluate how the addition of Hepion Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.

Is Hepion Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Hepion Pharmaceuticals. If investors know Hepion will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Hepion Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Hepion Pharmaceuticals is measured differently than its book value, which is the value of Hepion that is recorded on the company's balance sheet. Investors also form their own opinion of Hepion Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Hepion Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Hepion Pharmaceuticals' market value can be influenced by many factors that don't directly affect Hepion Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Hepion Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Hepion Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Hepion Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.